- Home
- PEPG vs BODI Comparison
PEPG vs BODI Comparison
Compare PEPG & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- BODI
- Stock Information
- Founded
- PEPG 2018
- BODI 1998
- Country
- PEPG United States
- BODI United States
- Employees
- PEPG N/A
- BODI N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- BODI Industrial Machinery/Components
- Sector
- PEPG Health Care
- BODI Industrials
- Exchange
- PEPG Nasdaq
- BODI Nasdaq
- Market Cap
- PEPG 45.9M
- BODI 40.1M
- IPO Year
- PEPG 2022
- BODI N/A
- Fundamental
- Price
- PEPG $1.49
- BODI $5.53
- Analyst Decision
- PEPG Buy
- BODI Buy
- Analyst Count
- PEPG 3
- BODI 2
- Target Price
- PEPG $7.67
- BODI $10.00
- AVG Volume (30 Days)
- PEPG 335.1K
- BODI 14.8K
- Earning Date
- PEPG 11-06-2025
- BODI 08-05-2025
- Dividend Yield
- PEPG N/A
- BODI N/A
- EPS Growth
- PEPG N/A
- BODI N/A
- EPS
- PEPG N/A
- BODI N/A
- Revenue
- PEPG N/A
- BODI $324,871,000.00
- Revenue This Year
- PEPG N/A
- BODI N/A
- Revenue Next Year
- PEPG N/A
- BODI N/A
- P/E Ratio
- PEPG N/A
- BODI N/A
- Revenue Growth
- PEPG N/A
- BODI N/A
- 52 Week Low
- PEPG $0.88
- BODI $3.38
- 52 Week High
- PEPG $10.06
- BODI $8.71
- Technical
- Relative Strength Index (RSI)
- PEPG 64.86
- BODI 58.26
- Support Level
- PEPG $1.13
- BODI $5.12
- Resistance Level
- PEPG $1.32
- BODI $6.42
- Average True Range (ATR)
- PEPG 0.09
- BODI 0.44
- MACD
- PEPG 0.03
- BODI -0.01
- Stochastic Oscillator
- PEPG 87.80
- BODI 43.31
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.